Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by stockman75on Nov 07, 2016 6:11pm

126 Views

Post# 25434389

RE:RE:RE:RE:Biotech stocks up 4 % in US market double the broad market

I have similar thoughts... if the analysts disagree then they should state that they disagree and why they disagree with management numbers versus completely ignoring the information. The burden of proof then seems to reside with the analysts or if they are discounting due to lack of trust then at minimum state that. By not stating anything then we have to conclude it is not really lack of trust but rather lack of competency.

Bullboard Posts

The long-term forecast for lithium stocks in 2024